Quick Summary
Covering the latest research from top Wall Street investment banks

TerraPower Nuclear Technology Backed by Meta, Countdown to Commercial Operation by 2031

Institution
J.P. Morgan, SEC
Date
20260615
Authors
Aidan C. Kelly, Eli Jossen, Diana Niles, Francina Kolluri, Vrathan Reddy
Company
Essent, Meta Platforms, TerraPower
Ticker
ESNT, META, TERRAPOWER
Industry
Insurance - Specialty, Internet Content & Information, AR, Energy, Nuclear Power
Rating
BullishMedium confidenceLong-termThe report takes a positive view of TerraPower's technology roadmap, customer expansion, and cost outlook, highlighting Meta's partnership as a 'clear vote of confidence.' It also sees the medical isotope business as providing a meaningful cash flow bridge for long-term commercialization, though no formal rating or price target is given.
AuthorsAidan C. Kelly, Eli Jossen, Diana Niles, Francina Kolluri, Vrathan Reddy
CoverageUnited States
Asset classesOther
Business segmentsNatrium Sodium-Cooled Fast Reactor Development、Medical Isotope Business
Research firm divisions/subsidiariesJ.P. Morgan Securities LLC(Subsidiary/Legal Entity)、North America Power(Division/Team)

AI summary card

TerraPower Nuclear Technology Backed by Meta, Countdown to Commercial Operation by 2031

Highlights from J.P. Morgan’s fireside chat with TerraPower executives, focusing on the progress of the Natrium sodium-cooled fast reactor technology, Meta’s strategic partnership, supply chain deployment, and the near-term cash flow value of the medical isotope business.

Data Center EnergySmall Modular ReactorsNuclear PowerTerraPowerMetaHALEU FuelMedical IsotopesU.S. Energy Policy
  • Meta selected TerraPower’s Natrium design through a rigorous RFP process, providing milestone development funding
  • The reactor can ramp up from 345 MW baseload to over 500 MW peak within 10 minutes, offering exceptional load-following capability
  • NOAK levelized cost of electricity (LCOE) could fall below $90/MWh, and even lower at $60/MWh or less with ITC
  • Strategic partnerships established with Korean firms such as KHNP, SK, and Hyundai to address supply chain bottlenecks
  • The medical isotope business generated about $1 billion in revenue this year, serving as a cash flow bridge for long-term power commercialization
  • Kemmerer Unit 1 aims for commercial operation by 2031 and has applied for operating license in 2028
  • FOAK financing remains the primary variable for scaling deployment, and government support is indispensable

Report interpretation

Overview

This J.P. Morgan report captures highlights from its fireside chat with Steven Hellman, TerraPower’s Executive Vice President and CFO, as part of the ‘Powering Data Centers’ series. The core focus is TerraPower’s latest progress on the Natrium sodium-cooled fast reactor technology: following the partnership with Meta in January 2025 and the groundbreaking of Kemmerer Unit 1 in April 2025, the company is now advancing toward commercial operation by 2031. The report also reveals key developments in TerraPower’s customer expansion, supply chain collaboration, regulatory approvals, and financing, as well as the strategic value of the medical isotope business as a near-term cash flow source.

Core views

On the technical front, the Natrium reactor design stands out for its exceptional load-following capability—able to ramp up from 345 MW baseload to over 500 MW peak within just 10 minutes without increasing construction costs. This feature allows it to flexibly serve diverse customer types, including hyperscale data center operators needing stable baseload power and traditional utilities requiring peak-shaving capacity. Meta chose the Natrium design after a rigorous RFP process among multiple reactor concepts, which is seen as a 'clear vote of confidence' in this technology path. In terms of customer expansion, TerraPower is building a diversified customer base. As an anchor customer, Meta not only selected TerraPower’s technology but also provided milestone development funding covering early engineering, site selection, and regulatory work, helping mitigate capital risks for the first-of-a-kind unit (FOAK). Besides hyperscale cloud providers, emerging cloud service providers and chipmakers have shown interest—but these competitors face weaker balance sheets. While utilities are interested, they face risks of cost overruns and constraints on end-user electricity price affordability. Costs and financing are highlighted as critical variables in the report. The conversation estimated that the NOAK (next-generation plant) levelized cost of electricity (LCOE) could drop below $90/MWh, and further down to $60/MWh or lower when factoring in the investment tax credit (ITC). However, financing arrangements outside of government support remain the key constraint for large-scale SMR deployment. TerraPower management made it clear that government support remains crucial, with FOAK financing taking priority even over supply chain and fuel issues. In terms of supply chain deployment, TerraPower directly addresses industry bottlenecks through strategic partnerships with Korean companies. Partners such as Korea Hydro & Nuclear Power (KHNP), SK, and Hyundai hold equity stakes and bring along affiliated companies with global nuclear power plant construction experience, providing important space for future projects. On the fuel side, each plant will require about 15 tons of high-assay low-enriched uranium (HALEU); the fuel supply for the first unit has already been secured through the U.S. Department of Energy (DOE), and TerraPower is working with Framatome to build a dedicated fuel manufacturing facility, aiming for completion by 2030.

Analysis framework

This transcript adopts a five-dimensional analytical framework—‘technology validation—customer endorsement—supply chain assurance—financing feasibility—regulatory advancement’—to evaluate TerraPower’s path from lab to commercialization layer by layer. The firm obtained first-hand information through direct executive conversations, cross-validating technical parameters (power ramp-up speed, construction costs), commercial progress (customer contract structures, revenue recognition methods), and the policy environment (regulatory approval pace, government subsidy intensity) to form a comprehensive judgment on project viability. Notably, the report breaks down TerraPower’s business model into two time dimensions: ‘long-term power’ and ‘near-term isotopes.’ The former represents a distant asset to be realized by 2031, while the latter is a cash-flow business already listed in 2024 and expected to reach $1 billion in revenue by 2026. This ‘dual-track’ analysis helps investors understand the company’s survival capabilities and valuation support during the commercialization gap.

Methodology notes

  • Industry/Industrial Analysis FrameworkSupply-demand framework

    Nuclear power industry analysis must simultaneously consider the alignment between demand-side (data centers, utilities, etc., power buyers) and supply-side (reactor technology, fuel, construction capacity) factors

    This report categorizes TerraPower’s potential customers by their payment ability and demand characteristics (hyperscale cloud providers, emerging cloud providers, chipmakers, utilities) and analyzes the supply-side elements—including fuel (HALEU), construction capacity (Korean partners), and regulatory approval bottlenecks—reflecting the application of the supply-demand framework in assessing the commercialization of emerging nuclear technologies

  • Industry/Industrial Analysis FrameworkUpstream-Midstream-Downstream Supply Chain Transmission

    The nuclear power supply chain—from upstream fuel supply, midstream equipment manufacturing, to downstream power sales—has tight transmission links; any bottleneck in one stage will affect the overall project economics

    The report specifically analyzes TerraPower’s layout across various supply chain stages: upstream through DOE and Framatome securing HALEU fuel supply, midstream leveraging Korean partners’ construction capacity, and downstream locking in anchor customers like Meta—demonstrating the use of supply chain analysis in assessing the risk of the first unit’s implementation

  • Valuation Methodology

    The levelized cost of electricity (LCOE) is the core metric for evaluating the economic viability of power generation technologies, reflecting the leveled cost per kilowatt-hour over the full lifecycle

    The report uses NOAK LCOE (below $90/MWh) and subsidized LCOE (at $60/MWh or lower) as key quantitative indicators to measure the competitiveness of the Natrium technology—a standard method for comparing costs of different power generation technologies in the electricity sector

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Meta (META.US)
    Anchor customer of TerraPower, selected Natrium design through rigorous RFP and provided milestone development funding
    Strengths
    Strong balance sheet, providing critical capital risk mitigation for the FOAK project
    Comparison
    Compared to emerging cloud providers and chipmakers, Meta’s financial commitment is more credible

Key data

  • Natrium Reactor Baseload Power345MWCan ramp up to over 500 MW peak within 10 minutes
  • NOAK Levelized Cost of Electricity (LCOE)under $90/MWhCould reach $60/MWh or lower with investment tax credit (ITC)
  • HALEU Fuel Requirement per Plant~15 metric tonsFuel supply for the first unit has already been secured through DOE
  • 2026 Medical Isotope Business Revenue Forecast~$1bnActinium-225 targeted cancer therapy provides a cash flow bridge for long-term power commercialization
  • Total DOE ARDP Funding$3.2bnFor development of two reactors (TerraPower and X-energy); $2bn already disbursed, with subsequent costs split 50/50
  • Kemmerer Unit 1 Key MilestonesGroundbreaking in April 2025, first concrete poured in November 2025, application for operating license in 2028, commercial operation by 2031Preparatory energy island work started in June 2024

Impact & implications

For TerraPower, Meta’s strategic partnership carries dual significance: it serves as third-party validation of the technology pathway and sets an example for innovative financing structures for the FOAK project. The milestone development funding arrangement could provide a replicable template for attracting corporate power purchase agreements (CPPAs) in the nuclear industry, lowering the capital threshold for subsequent projects. For the data center energy sector, Natrium’s load-following capability (rapid switching from baseload to peak) distinguishes it from traditional baseload nuclear power, better matching the actual power demand curves of data centers. If the NOAK cost targets are met, advanced nuclear power will become economically competitive with renewable energy plus storage solutions in the data center decarbonization journey. For investors, it’s important to pay attention to the risk-return characteristics across two time horizons: in the short term (2026–2030), the execution and cash flow generation capacity of the medical isotope business; and in the long term (after 2031), the continuity of nuclear power commercialization policies and changes in the financing environment.

Risks

  • FOAK (first-of-a-kind plant) financing is the primary variable for scaling deployment, and government support is indispensable
  • The supply chain is still in its early stages, and advanced nuclear power faces supply chain bottlenecks
  • Potential customers such as emerging cloud providers and chipmakers have weaker balance sheets
  • Utilities face risks of cost overruns and constraints on end-user electricity price affordability
  • The project timeline is long (commercial operation by 2031), with uncertainties around the policy environment and subsidy intensity during that period

What to watch

  • Construction progress of Kemmerer Unit 1: first concrete poured in November 2025, application for operating license in 2028, commercial operation by 2031
  • Disbursement of subsequent DOE ARDP funds and implementation of the 50/50 cost-sharing mechanism
  • Progress on the HALEU fuel manufacturing facility built in partnership with Framatome (aiming for completion by 2030)
  • Production ramp-up and revenue growth of the medical isotope business
  • New customer signings beyond Meta, especially among hyperscale cloud providers and utilities
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins